Tracking 1000 cancer patients to see if targeted drug delivery helps them live longer
NCT ID NCT06805461
Summary
This study is a registry that will follow 1000 adults with solid tumors who receive a targeted treatment. The treatment involves delivering chemotherapy drugs directly to the tumor using a special catheter called RenovoCath. The main goal is to collect real-world information on the safety of the procedure and track how long patients live after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baptist Health South Florida
RECRUITINGCoral Gables, Florida, 33143, United States
Contact
-
The University of Vermont Medical Center
RECRUITINGBurlington, Vermont, 05401, United States
Contact
-
University of Pennsylvania Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact
Conditions
Explore the condition pages connected to this study.